Related references
Note: Only part of the references are listed.Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
Paulina Grygielewicz et al.
GASTRIC CANCER (2016)
Role of retinoic acid receptor (RAR) signaling in post-natal male germ cell differentiation
Manuel Mark et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer
L. G. T. Lemos et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Acute promyelocytic leukemia: where did we start, where are we now, and the future
C. C. Coombs et al.
BLOOD CANCER JOURNAL (2015)
Treatment of early-stage HER2+ breast cancer-an evolving field
Arlindo R. Ferreira et al.
ECANCERMEDICALSCIENCE (2015)
Targeted therapies in cancer and mechanisms of resistance
Simona Corso et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia
Melanie L. Ufkin et al.
LEUKEMIA RESEARCH (2014)
Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region
K. Sakamoto et al.
BLOOD CANCER JOURNAL (2014)
Genetics and molecular biology: the role of retinoic acid receptor genes in acute promyelocytic leukemia
Jillian Davidson et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia
Guilherme Augusto dos Santos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The Lost Intrinsic Fragmentation of MAT1 Protein During Granulopoiesis Promotes the Growth and Metastasis of Leukemic Myeloblasts
Siyue Lou et al.
STEM CELLS (2013)
Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study
Patrice Chevallier et al.
BLOOD (2012)
Thrombomodulin enhances the antifibrinolytic and antileukemic effects of all-trans retinoic acid in acute promyelocytic leukemia cells
Takayuki Ikezoe et al.
EXPERIMENTAL HEMATOLOGY (2012)
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
J. Congleton et al.
LEUKEMIA (2012)
The stimulation of osteogenic differentiation of human adipose-derived stem cells by ionic products from akermanite dissolution via activation of the ERK pathway
Huijie Gu et al.
BIOMATERIALS (2011)
ERK signaling controls blastema cell differentiation during planarian regeneration
Junichi Tasaki et al.
DEVELOPMENT (2011)
Designer lymphocytes to fight cancer: a helping hand from modern molecular biology
Rolf Kiessling
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
Mustafa Benekli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment
Chia-Lin Hsu et al.
BLOOD (2007)
Signal transduction pathways that contribute to myeloid differentiation
M. B. Miranda et al.
LEUKEMIA (2007)
Inhibition of monocytic differentiation by phosphorylation-deficient Stat1 is associated with impaired expression of Stat2, ICSBP/IRF8 and C/EBPε
A. Dimberg et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
Donald W. Milligan et al.
BLOOD (2006)
Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo
Joji Nagasawa et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
New targets for therapy in breast cancer - Small molecule tyrosine kinase inhibitors
NU Lin et al.
BREAST CANCER RESEARCH (2004)
The future of cytotoxic therapy: selective cytotoxicity based on biology is the key
JS de Bono et al.
BREAST CANCER RESEARCH (2003)
The promise of retinoids to fight against cancer
L Altucci et al.
NATURE REVIEWS CANCER (2001)
Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia
JI Martín-Subero et al.
CANCER GENETICS AND CYTOGENETICS (2001)
Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases
M Gianni et al.
CELL DEATH AND DIFFERENTIATION (2000)
Share Paper
